TRUE Private Wealth Advisors Raises Stake in UnitedHealth Group Incorporated $UNH

TRUE Private Wealth Advisors lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 250.3% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,552 shares of the healthcare conglomerate’s stock after buying an additional 1,109 shares during the period. TRUE Private Wealth Advisors’ holdings in UnitedHealth Group were worth $484,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. Brighton Jones LLC lifted its position in UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after purchasing an additional 28,231 shares during the period. Revolve Wealth Partners LLC lifted its holdings in UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after acquiring an additional 2,324 shares during the period. SYM FINANCIAL Corp lifted its stake in shares of UnitedHealth Group by 10.8% in the first quarter. SYM FINANCIAL Corp now owns 3,158 shares of the healthcare conglomerate’s stock valued at $1,654,000 after purchasing an additional 309 shares during the period. Venturi Wealth Management LLC increased its holdings in UnitedHealth Group by 17.0% in the first quarter. Venturi Wealth Management LLC now owns 37,146 shares of the healthcare conglomerate’s stock valued at $19,455,000 after buying an additional 5,393 shares in the last quarter. Finally, Forbes J M & Co. LLP raised its holdings in UnitedHealth Group by 2.7% during the first quarter. Forbes J M & Co. LLP now owns 19,097 shares of the healthcare conglomerate’s stock worth $10,002,000 after purchasing an additional 502 shares during the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

Shares of UNH stock opened at $309.19 on Thursday. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $622.83. The company has a 50 day moving average price of $346.20 and a 200 day moving average price of $317.57. The firm has a market capitalization of $280.08 billion, a price-to-earnings ratio of 16.14, a price-to-earnings-growth ratio of 2.28 and a beta of 0.47. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.82.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. The business had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business’s revenue for the quarter was up 12.2% on a year-over-year basis. During the same period in the prior year, the firm posted $7.15 EPS. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be given a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date of this dividend is Monday, December 8th. UnitedHealth Group’s payout ratio is 46.14%.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of research reports. TD Cowen increased their price objective on shares of UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a research note on Thursday, October 30th. Piper Sandler cut their price objective on UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a research report on Tuesday, October 28th. Sanford C. Bernstein increased their target price on UnitedHealth Group from $433.00 to $440.00 and gave the company an “outperform” rating in a report on Thursday, October 30th. Truist Financial upped their price objective on UnitedHealth Group from $310.00 to $365.00 and gave the company a “buy” rating in a research report on Tuesday, September 9th. Finally, Deutsche Bank Aktiengesellschaft cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price target on the stock. in a research note on Wednesday, October 29th. Eighteen analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $397.12.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.